Sulfafurazole
Not to be confused with sulfadiazine.
Systematic (IUPAC) name | |
---|---|
4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a601049 |
Pregnancy category |
|
Legal status |
|
Routes of administration | Oral |
Pharmacokinetic data | |
Excretion | Excreted unchanged in urine |
Identifiers | |
CAS Number | 127-69-5 |
ATC code | J01EB05 S01AB02 QJ01EQ05 |
PubChem | CID 5344 |
DrugBank | DB00263 |
UNII | 740T4C525W |
KEGG | D00450 |
ChEMBL | CHEMBL453 |
Chemical data | |
Formula | C11H13N3O3S |
Molar mass | 267.30 g/mol |
| |
Physical data | |
Melting point | 194 °C (381 °F) |
(what is this?) (verify) |
Sulfafurazole (INN, also known as sulfisoxazole) is a sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of Gram-negative and Gram-positive organisms. It is sometimes given in combination with erythromycin (see erythromycin/Sulfafurazole) or phenazopyridine. It is used locally in a 4% solution or ointment.
Synthesis
See also
External links
- Sulfisoxazole at the US National Library of Medicine Medical Subject Headings (MeSH)
- MedlinePlus DrugInfo medmaster-a601049
- MedlinePlus DrugInfo medmaster-a601115
- DDB 30455
|
This article is issued from Wikipedia - version of the Monday, November 30, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.